Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
about
Carbapenems: past, present, and futureUpdated functional classification of beta-lactamasesAvibactam and Class C -Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for ResistanceComparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae.Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.Characterization of a novel AmpC β-lactamase produced by a carbapenem-resistant Cedecea davisae clinical isolate.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.AmpC beta-lactamases.Altered Outer Membrane Transcriptome Balance with AmpC Overexpression in Carbapenem-Resistant Enterobacter cloacaeOccurrence of bla DHA-1 mediated cephalosporin resistance in Escherichia coli and their transcriptional response against cephalosporin stress: a report from India.Proliferation and significance of clinically relevant β-lactamases.Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing.Characterization of OXA-204, a carbapenem-hydrolyzing class D β-lactamase from Klebsiella pneumoniae.Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithmPER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumanniiDetection of carbapenemase producers in Enterobacteriaceae by use of a novel screening mediumPhenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii.Extended-spectrum cephalosporinase in Acinetobacter baumannii.Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency.Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates.Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animalsEvaluation of ROSCO Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae.Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009).
P2860
Q24634999-4BD46E84-C823-4024-9D4F-46A5AD5CB015Q24644798-819F74DB-BDFC-4466-BF63-FB12F73898E3Q27684678-25561B29-4262-40AF-952A-EABF32915EB3Q33656285-CC505E4B-83E7-4454-AD28-37D95A2FBC70Q33962811-C90ED532-8249-4B2A-9F4C-F40E365AF9A4Q34596825-138778A8-FF46-4707-AD1A-E9C307CA8E65Q35007624-C36887C2-35E8-4AD6-A2AB-818150BCE960Q35806387-01182CB5-83EC-40AE-B6FF-D7F5E0E5D7F7Q37274713-1D844B0F-6050-440F-848B-D5278B8DB82DQ37366249-B984015A-BE89-4D5D-A098-B1FEB20B0C1DQ37528489-F21BE87B-504D-47A3-847D-48F829B4EB1BQ37713480-3E531EF1-071D-480C-95BE-4039110CA5B6Q38076454-74B2BAA9-E189-41F4-AEAA-8500521F3BDCQ38282628-384245B1-BA3F-4542-B4AC-9E79CDBE8C82Q38282766-270E97C9-6EEA-4E9E-B800-322E8ACB960CQ39365410-6EDAAC7C-E77B-4088-855D-A94708F513E0Q40567310-D941F983-CF1D-4EA0-8CCF-6C0D76BBC938Q41508049-D83373CA-00B9-44A9-85D2-660E4BBA8709Q41621778-15FAF8D2-22F3-48B8-B92B-D6FBF25EBF91Q41684782-900E457D-6409-4109-B137-76078CDCB12EQ41901517-09A9F71E-52E6-408E-9AFB-A0EC576D6538Q42280677-6BE96DCC-5916-46F7-89D3-F464C9371446Q42375906-B82364D1-34C6-421F-8CE6-BC1269B8B42AQ42376054-34AED835-DA8B-451B-9FDF-2AEEC92BD803Q42576942-9A552E55-C87C-415C-BBD8-DBCA47261E6EQ43128351-9B8E9C0C-62B0-446C-B640-313D7A2C72EDQ43195360-28A65A61-38D3-43B4-A446-4CBB99C59414Q43215482-F828B6BA-043C-4CCE-A2C7-A5C9CF02435AQ44095874-6C9B8333-F164-4379-861B-678273595FC6Q46884279-9B4F2800-1A04-4631-A5B2-05E1970FEE41Q47150482-82F7483F-9B71-429C-A046-42DAA899C646Q47279767-695D52E8-EED5-4AA9-BF3D-25E06B238B1CQ50948247-89229B35-B11E-41D5-BC80-7ABA66DC6715
P2860
Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Contribution of extended-spect ...... esistance in Escherichia coli.
@en
Contribution of extended-spectrum AmpC
@nl
type
label
Contribution of extended-spect ...... esistance in Escherichia coli.
@en
Contribution of extended-spectrum AmpC
@nl
prefLabel
Contribution of extended-spect ...... esistance in Escherichia coli.
@en
Contribution of extended-spectrum AmpC
@nl
P2093
P1476
Contribution of extended-spect ...... esistance in Escherichia coli.
@en
P2093
Amira Berkani
François Eb
Hedi Mammeri
P304
P356
10.1111/J.1574-6968.2008.01126.X
P577
2008-03-27T00:00:00Z